Page last updated: 2024-11-05

creatinol phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Creatinol phosphate, also known as creatine phosphate, is a naturally occurring compound in the body that plays a crucial role in energy production. It is synthesized from creatine and phosphate, primarily in the liver and kidneys. Creatinol phosphate acts as a high-energy phosphate donor, providing a readily available source of energy for muscle contraction. During intense exercise, when ATP levels decline, creatinol phosphate rapidly donates its phosphate group to ADP, regenerating ATP. This allows for sustained muscle activity for a short period. Creatinol phosphate is a key component of the phosphagen system, which provides the initial burst of energy for high-intensity activities. Research on creatinol phosphate focuses on its potential benefits in enhancing athletic performance, promoting muscle growth and recovery, and potentially mitigating age-related muscle decline. Studies have investigated the effects of creatinol phosphate supplementation on muscle strength, power, and endurance. However, the long-term effects and potential risks of high-dose supplementation remain under investigation.'

creatinol phosphate: minor descriptor (75-85); on-line & Index Medicus search CREATINE/AA (75-85); RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23342
CHEMBL ID2104114
CHEBI ID134856
SCHEMBL ID672284
MeSH IDM0262897

Synonyms (58)

Synonym
guanidine, n-methyl-n-(2-(phosphonooxy)ethyl)-,
creatinolfosfate [inn]
einecs 230-011-8
1-(2-hydroxyethyl)-1-methylguanidine dihydrogen phosphate (ester)
creatinol phosphate
aplodan
creatinol o-phosphate
guanidine, 1-(2-hydroxyethyl)-1-methyl-, dihydrogen phosphate (ester)
creatinolfosfate
creatinolfosfato [inn-spanish]
n-methyl-n-(beta-hydroxyethyl)guanidine o-phosphate
n-methyl-n-(beta-hydroxyaethyl)guanidine-o-phosphat [german]
creatinolo o-fosfato [italian]
n-methyl-n-(2-(phosphonooxy)ethyl)guanidine
brn 1911880
creatinolfosfatum [inn-latin]
creatinolfosfate (inn)
D07162
6903-79-3
COP ,
CHEBI:134856
2-[carbamimidoyl(methyl)amino]ethyl dihydrogen phosphate
FT-0656062
2-(1-methylguanidino)ethyl dihydrogen phosphate
A836322
creatinol-o-phosphate
AKOS006273435
CHEMBL2104114
gipron
n-methyl-n-(beta-hydroxyaethyl)guanidine-o-phosphat
unii-5o564rn1qd
creatinolfosfato
creatinolo o-fosfato
nergize
5o564rn1qd ,
creatinolfosfatum
2-(1-methylguanidino)ethyl dihydrogenphosphat
c4h12n3o4p
SCHEMBL672284
creatinolfosfate [who-dd]
DTXSID50219100
C2767
mfcd00868297
SR-01000945068-1
sr-01000945068
2-[[amino(imino)methyl](methyl)amino]ethyl dihydrogen phosphate
FOIPWTMKYXWFGC-UHFFFAOYSA-N
DB13071
AS-18502
Q6598844
BRD-K42991124-001-01-4
creatinol-phosphate
creatinolfosfate, creatinol phosphate
HY-107335
CS-0028169
EN300-7361831
[2-(n-methylcarbamimidamido)ethoxy]phosphonic acid
Z1198155511
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phosphoethanolamine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (90.48)18.7374
1990's1 (4.76)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (4.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.57 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index65.35 (26.88)
Search Engine Supply Index3.99 (0.95)

This Compound (29.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (28.57%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]